大型美国医疗系统中COVID-19 XBB.1.5疫苗接种覆盖率差异:不同种族和族裔群体的分解分析
该回顾性队列纳入2023年9月12日至2024年4月30日Kaiser Permanente南加州成年成员,分析COVID-19 XBB.1.5疫苗接种的种族和族裔差异。在2,621,148名符合分解分析条件的成员中,非西班牙裔白人、西班牙裔和非西班牙裔黑人的接种率分别为25.5%、15.5%和19.7%。分解分析显示,西班牙裔与非西班牙裔白人之间差异的78.9%和非西班牙裔黑人与非西班牙裔白人之间差异的86.2%可由观察到的风险因素解释。
要点
- 非西班牙裔白人、西班牙裔和非西班牙裔黑人COVID-19 XBB.1.5疫苗接种率分别为25.5%、15.5%和19.7%。
- 西班牙裔与非西班牙裔白人接种差异的78.9%可由观察到的风险因素解释。
- 非西班牙裔黑人与非西班牙裔白人接种差异的86.2%可由观察到的风险因素解释。
核心结论
- COVID-19 XBB.1.5疫苗接种的种族和族裔差异在很大程度上可由年龄、社会经济状况和医疗保健利用的差异解释。
- 研究结果强调需要有针对性的干预措施,特别是针对年轻人群和高剥夺社区,以及利用门诊就诊提高疫苗接种率。
研究设计与样本
- 回顾性队列研究,纳入2023年9月12日至2024年4月30日期间Kaiser Permanente南加州成年成员。
- 采用多变量逻辑回归评估人口学因素、以社区剥夺指数(NDI)衡量的社会经济状况、临床因素和医疗保健利用与疫苗接种的关联。
- 进行Blinder-Oaxaca分解分析,量化13个风险因素对西班牙裔、非西班牙裔黑人和非西班牙裔白人之间疫苗接种率差异的解释程度。
主要发现
- 在2,621,148名符合分解分析条件的成员中,非西班牙裔白人、西班牙裔和非西班牙裔黑人的COVID-19 XBB.1.5疫苗接种率分别为25.5%、15.5%和19.7%。
- 以非西班牙裔白人为参照组,年龄分布差异解释西班牙裔个体差异的22.3%和非西班牙裔黑人个体差异的11.5%。
- 以非西班牙裔白人为参照组,NDI解释西班牙裔个体差异的12.0%和非西班牙裔黑人个体差异的21.2%。
- 以非西班牙裔白人为参照组,既往流感疫苗接种和既往二价COVID-19疫苗接种差异分别解释西班牙裔个体差异的10.5%和29.3%,以及非西班牙裔黑人个体差异的30.8%和19.3%。
- 排除既往疫苗接种史后,年龄和NDI解释的差异份额大幅增加。
临床怎么用
- 作者认为,研究结果强调需要有针对性的干预措施,特别是针对年轻人群和高剥夺社区,以及利用门诊就诊提高疫苗接种率。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Differences in COVID-19 vaccination coverage across racial and ethnic groups have been widely documented in the U.S. We conducted Blinder-Oaxaca decomposition analyses to examine the contribution of 13 risk factors to COVID-19 XBB.1.5 vaccination differences across racial and ethnic groups within a large U.S. healthcare system. METHODS: The retrospective cohort included adult members of Kaiser Permanente Southern California between September 12, 2023, and April 30, 2024. The outcome was COVID-19 XBB.1.5 vaccination. We used multivariable logistic regression to assess the association of demographic factors, socioeconomic status measured by neighborhood deprivation index (NDI), clinical factors, and healthcare utilization with vaccination. Decomposition analyses were performed to quantify the extent to which differences in these factors explained differences in vaccination rates between Hispanic, non-Hispanic Black, and non-Hispanic White individuals. RESULTS: Among 2,621,148 members eligible for decomposition analyses, COVID-19 XBB.1.5 vaccination rates were 25.5%, 15.5% and 19.7% for non-Hispanic White, Hispanic, and non-Hispanic Black individuals, respectively. Decomposition analyses showed that 78.9% of the vaccination difference between Hispanic and non-Hispanic White individuals and 86.2% of the difference between non-Hispanic Black and non-Hispanic White individuals were explained by observed risk factors. With non-Hispanic White individuals serving as the reference group, differences in age distribution explained 22.3% of the difference for Hispanic individuals and 11.5% for non-Hispanic Black individuals, and NDI explained 12.0% and 21.2%, respectively; differences in prior season influenza vaccination and prior bivalent COVID-19 vaccination accounted for 10.5% and 29.3% of the difference for Hispanic individuals, and 30.8% and 19.3% for non-Hispanic Black individuals, respectively. When prior vaccination history was excluded, the share of the difference explained by age and NDI increased substantially. CONCLUSION: Differences in COVID-19 XBB.1.5 vaccination across race/ethnicity were largely explained by differences in age, socioeconomic status, and healthcare utilization. The findings underscore the need for targeted interventions, particularly in younger populations and highly deprived neighborhoods, as well as leveraging outpatient visits to improve vaccine uptake.
引用
- Xu S, Sy LS, Contreras R, et al. Differences in COVID-19 XBB.1.5 vaccination coverage: A decomposition analysis across racial and ethnic groups in a large U.S. healthcare system. Vaccine. 2025. PMID: 40768844. doi:10.1016/j.vaccine.2025.127577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。